Frank J. Williams - 23 Aug 2022 Form 4 Insider Report for Evolent Health, Inc. (EVH)

Role: Director
Signature: /s/ Jonathan Weinberg, Attorney-in-fact
Issuer symbol: EVH
Transactions as of: 23 Aug 2022
Net transactions value: -$5,949,500
Form type: 4
Filing time: 25 Aug 2022, 16:37:16 UTC
Previous filing: 13 Jun 2022
Next filing: 03 Nov 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	EVH	Class A Common Stock	Options Exercise	$576,000	+150,000	+20%	$3.84^*	902,434	23 Aug 2022	Direct	F1
transaction	EVH	Class A Common Stock	Sale	$5,362,500	-150,000	-17%	$35.75	752,434	23 Aug 2022	Direct	F1, F2
transaction	EVH	Class A Common Stock	Options Exercise	$697,500	+50,000	+6.6%	$13.95	802,434	24 Aug 2022	Direct	F1
transaction	EVH	Class A Common Stock	Sale	$1,860,500	-50,000	-6.2%	$37.21	752,434	24 Aug 2022	Direct	F1, F3
holding	EVH	Class A Common Stock						66,064	23 Aug 2022	See footnote	F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	EVH	Class A Common Stock Option (right to buy)	Options Exercise	$0	-150,000	-25%	$0.000000	449,060	23 Aug 2022	Class A Common Stock	150,000	$3.84	Direct	F5
transaction	EVH	Class A Common Stock Option (right to buy)	Options Exercise	$0	-50,000	-22%	$0.000000	177,273	24 Aug 2022	Class A Common Stock	50,000	$13.95	Direct	F6

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission.
F2	The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.53 to $36.24, inclusive. The reporting person undertakes to provide to Evolent Health, Inc., any security holder of Evolent Health, Inc., or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F3	The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $37.00 to $37.58, inclusive. The reporting person undertakes to provide to Evolent Health, Inc., any security holder of Evolent Health, Inc., or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F4	Shares held of record by the Frank Williams Irrevocable Trust. Mr. Williams serves as the Trustee of the Frank Williams Irrevocable Trust.
F5	The Class A Common Stock Options exercised vested on December 1, 2014 and December 1, 2015.
F6	The Class A Common Stock Option exercised vested on February 1, 2019.